# FDA WARNING_LETTER - Allure Imports - March 31, 2021

Source: https://www.keypedia.com/records/warning_letter/allure-imports/711d9dfb-0b0f-4e19-86ea-41914a1c552a

> FDA WARNING_LETTER for Allure Imports on March 31, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Allure Imports
- Inspection Date: 2021-03-31
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: On April 7, 2021, the FDA and FTC issued a Warning Letter to the recipient regarding unapproved and misbranded products related to COVID-19. The FDA and FTC reviewed websites www.facedoctor.ca, www.vitalityc60.com, and www.allureimports.com, and associated social media, on February 25, 2021, and March 31, 2021.

The FDA observed that "Silver Soul Immune Support," "Silver Soul Body Spray," and "Vitality C60" were offered for sale in the U.S. and intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people. These products are unapproved new drugs, violating section 505(a) of the FD&C Act, and misbranded drugs under section 502. "Vitality C60" is also intended for COVID-19 mitigation/treatment/prevention in animals, making it an unsafe and adulterated drug under sections 512(a) and 501(a)(5) of the FD&C Act, as it lacks required approvals.

The letter cites specific claims from the websites and social media, such as "Colloidal Silver for Coronavirus" and claims that C60 "boosts dogs' immune systems" and helps "fight off this novel pathogen."

The

## Related Officers

- [Director](https://www.keypedia.com/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Director - Division of Compliance](https://www.keypedia.com/people/eric-m-nelson/301ef659-ae6a-41c5-9a3e-9cfbc0369670)
- [Associate Director](https://www.keypedia.com/people/serena-viswanathan/7d1b292d-1f22-42ff-8452-0bc9673b8326)

Company: https://www.keypedia.com/companies/allure-imports/584a032c-c0bd-4c34-b8f8-c9e099bd8eb7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c